Skip to main content
. Author manuscript; available in PMC: 2012 Apr 1.
Published in final edited form as: Prostate. 2010 Oct 13;71(5):498–506. doi: 10.1002/pros.21267

Table 3. Age-adjusted Relative Risks of Prostate Cancer by AMACR Genotypes and Disease Aggressiveness* in Caucasian Men.

SNP Genotype Less Aggressive More Aggressive p-value ˆ
rs34680
CC 1.00 (referent) 1.00 (referent)
CT + TT 1.12 (0.91 – 1.38) 0.91 (0.70 – 1.19) 0.15
rs34688
CC 1.00 (referent) 1.00 (referent)
CT + TT 1.09 (0.90 – 1.32) 0.96 (0.75 – 1.22) 0.32
rs250412
GG 1.00 (referent) 1.00 (referent)
GA + AA 1.00 (0.83 – 1.20) 0.99 (0.79 – 1.24) 0.92
rs2278008
TT 1.00 (referent) 1.00 (referent)
TC + CC 0.85 (0.71 – 1.02) 1.08 (0.87 – 1.36) 0.04
rs2287939
CC 1.00 (referent) 1.00 (referent)
CT + TT 0.81 (0.68 – 0.97) 1.06 (0.84 – 1.32) 0.02
rs2652130
AA 1.00 (referent) 1.00 (referent)
AC + CC 1.07 (0.87 – 1.32) 0.84 (0.63 – 1.10) 0.10
rs3195676
AA 1.00 (referent) 1.00 (referent)
AG + GG 0.90 (0.74 – 1.09) 0.84 (0.66 – 1.07) 0.58
rs6863657
GG 1.00 (referent) 1.00 (referent)
GA + AA 1.03 (0.82 – 1.29) 1.12 (0.84 – 1.48) 0.60
rs7721230
AA 1.00 (referent) 1.00 (referent)
AG + GG 0.94 (0.78 – 1.13) 0.89 (0.71 – 1.12) 0.69
rs10941112
AA 1.00 (referent) 1.00 (referent)
AG + GG 0.92 (0.76 – 1.12) 0.85 (0.67 – 1.08) 0.53
*

More aggressive cases were defined by a Gleason score of 7(4+3) or greater, or non-localized stage, or PSA > 20 ng/mL at time of diagnosis

ˆ

P-value from a likelihood ratio test for the difference in risk estimates for less versus more aggressive PCa.